{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:36:22Z","timestamp":1789378582639,"version":"build-2803163510"},"publisher-location":"Berlin, Heidelberg","reference-count":75,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642389641","type":"print"},{"value":"9783642389658","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-642-38965-8_5","type":"book-chapter","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T10:16:18Z","timestamp":1378376178000},"page":"75-95","source":"Crossref","is-referenced-by-count":34,"title":["Prevention of Hepatitis B Virus Infection and Liver Cancer"],"prefix":"10.1007","author":[{"given":"Mei-Hwei","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,6]]},"reference":[{"key":"5_CR1","first-page":"21s","volume":"2","author":"RP Beasley","year":"1982","unstructured":"Beasley RP (1982) Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic considerations. Hepatology 2:21s\u201326s","journal-title":"Hepatology"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","volume":"2","author":"RP Beasley","year":"1981","unstructured":"Beasley RP, Hwang LY, Lin CC et al (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 2:1129\u20131133","journal-title":"Lancet"},{"key":"5_CR3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/oxfordjournals.aje.a112370","volume":"105","author":"RP Beasley","year":"1977","unstructured":"Beasley RP, Trepo C, Stevens CE et al (1977) The e antigen and vertical transmission of hepatitis B surface antigen. Amer J Epidemiol 105:94\u201398","journal-title":"Amer J Epidemiol"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/bjs.6731","volume":"96","author":"S Braitenstein","year":"2009","unstructured":"Braitenstein S, Dimitroulis D, Petrowsky H et al (2009) Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis. Br J Surg 96:975\u2013981","journal-title":"Br J Surg"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-7069(02)06062-7","volume-title":"Viruses and liver cancer","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Ribes J (2002) The epidemiology of primary liver cancer: global epidemiology. In: Tabor E (ed) Viruses and liver cancer. Elsevier, Amsterdam, pp 1\u201316"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1535-6108(04)00058-3","volume":"5","author":"J Bruix","year":"2004","unstructured":"Bruix J, Boix L, Sala M et al (2004) Focus on hepatocellular carcinoma. Cancer Cell 5:215\u2013219","journal-title":"Cancer Cell"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix J, Sherman M (2005) Management of hepatocellular carcinoma AASLD Guideline recommendations for HCC screening. Hepatology 42:1208\u20131236","journal-title":"Hepatology"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","volume":"336","author":"MH Chang","year":"1997","unstructured":"Chang MH, Chen CJ, Lai MS et al (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336:1855\u20131859","journal-title":"N Engl J Med"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1002\/1097-0142(19891201)64:11<2377::AID-CNCR2820641130>3.0.CO;2-8","volume":"64","author":"MH Chang","year":"1989","unstructured":"Chang MH, Chen DS, Hsu HC et al (1989) Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 64:2377\u20132380","journal-title":"Cancer"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/hep.1840130218","volume":"13","author":"MH Chang","year":"1991","unstructured":"Chang MH, Chen PJ, Chen JY et al (1991) Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood. Heptology 13:316\u2013320","journal-title":"Heptology"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"7953","DOI":"10.1158\/1078-0432.CCR-05-1095","volume":"11","author":"MH Chang","year":"2005","unstructured":"Chang MH, Chen TH, Hsu HM et al (2005) Problems in the prevention of childhood hepatocellular carcinoma in the era of universal hepatitis B immunization. Clin Cancer Res 11:7953\u20137957","journal-title":"Clin Cancer Res"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/1097-0142(19840415)53:8<1807::AID-CNCR2820530835>3.0.CO;2-J","volume":"53","author":"MH Chang","year":"1984","unstructured":"Chang MH, Hsu HC, Lee CY et al (1984) Fraternal hepatocellular carcinoma in young children in two families. Cancer 53:1807\u20131810","journal-title":"Cancer"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S0168-8278(96)80262-5","volume":"24","author":"MH Chang","year":"1996","unstructured":"Chang MH, Hsu HY, Huang LM et al (1996) The role of transplacental hepatitis B core antibody in the mother-to-infant transmission of hepatitis B virus. J Hepatol 24:674\u2013679","journal-title":"J Hepatol"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1001\/jama.284.23.3040","volume":"284","author":"MH Chang","year":"2000","unstructured":"Chang MH, Shau WY, Chen CJ et al (2000) The effect of universal hepatitis B vaccination on hepatocellular carcinoma rates in boys and girls. JAMA 284:3040\u20133042","journal-title":"JAMA"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/jnci\/djp288","volume":"101","author":"MH Chang","year":"2009","unstructured":"Chang MH, You SL, Chen CJ et al (2009) Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 101:1348\u20131355","journal-title":"J Natl Cancer Inst"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J et al (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295:65\u201373","journal-title":"JAMA"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2008.03.073","volume":"135","author":"CL Chen","year":"2008","unstructured":"Chen CL, Yang HI, Yang WS et al (2008) Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B\/C infection: a follow-up study in Taiwan. Gastroenterology 135:111\u2013121","journal-title":"Gastroenterology"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1001\/jama.1987.03390190075023","volume":"257","author":"DS Chen","year":"1987","unstructured":"Chen DS, Hsu NHM, Sung JL et al (1987) A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 257:2597\u20132603","journal-title":"JAMA"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jama.1996.03540110060032","volume":"276","author":"HL Chen","year":"1996","unstructured":"Chen HL, Chang MH, Ni YH et al (1996) Seroepidemiology of hepatitis B virus infection in children: ten years after a hepatitis B mass vaccination program in Taiwan. JAMA 276:906\u2013908","journal-title":"JAMA"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.gastro.2011.12.035","volume":"142","author":"HL Chen","year":"2012","unstructured":"Chen HL, Lin LH, Hu FC et al (2012) Effects of maternal screening and universal immunization to prevent mother- to-infant transmission of HBV. Gastroenterology 142:773\u2013781","journal-title":"Gastroenterology"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/hep.23348","volume":"51","author":"YC Chen","year":"2010","unstructured":"Chen YC, Chu CM, Liaw YF (2010) Age- specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. Hepatology 51:435\u2013444","journal-title":"Hepatology"},{"key":"5_CR23","first-page":"475","volume":"66","author":"MC Chien","year":"1981","unstructured":"Chien MC, Tong MJ, Lo KJ et al (1981) Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan. J Natl Cancer Inst 66:475\u2013479","journal-title":"J Natl Cancer Inst"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/0264-410X(95)00056-7","volume":"13","author":"G Villa Da","year":"1995","unstructured":"Da Villa G, Picciottoc L, Elia S et al (1995) Hepatitis B vaccination: universal vaccination of newborn babies and children at 12\u00a0years of age versus high risk groups: a comparison in the field. Vaccine 13:1240\u20131243","journal-title":"Vaccine"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"14601","DOI":"10.1073\/pnas.251536898","volume":"98","author":"PA Egner","year":"2001","unstructured":"Egner PA, Wang JB, Shu YR et al (2001) Chlorophyline intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci USA 98:14601\u201314606","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/oxfordjournals.aje.a114497","volume":"125","author":"E Feret","year":"1987","unstructured":"Feret E, Larouze B, Diop B et al (1987) Epidemiology of hepatitis B virus infection in the rural community of tip, Senegal. Am J Epidemiol 125:140\u2013149","journal-title":"Am J Epidemiol"},{"key":"5_CR27","unstructured":"Ferlay J, Parkin DM, Curado MP, et al (2010) Cancer incidence in five continents, Volumes I to IX: IARC CancerBase No. 9 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. [\n                  http:\/\/ci5.iarc.fr\n                  \n                , accessed 26 Jan 2012]"},{"key":"5_CR28","first-page":"269","volume-title":"The molecular basis of human cancer","author":"JW Grisham","year":"2001","unstructured":"Grisham JW (2001) Molecular genetic alterations in primary hepatocellular neoplasms. In: Coleman WB, Tsongalis GJ (eds) The molecular basis of human cancer. Humana Press, Totowa, pp 269\u2013346"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","volume":"55","author":"GR Han","year":"2011","unstructured":"Han GR, Cao MK, Zhao W et al (2011) A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 55:1215\u20131221","journal-title":"J Hepatol"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00006454-199901000-00007","volume":"18","author":"NA Halsey","year":"1999","unstructured":"Halsey NA, Duclos P, van Damme P et al (1999) Hepatitis B vaccine and central nervous system demyelinating diseases. Pediatrc Infect Dis J 18:23\u201324","journal-title":"Pediatrc Infect Dis J"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ijc.2910280109","volume":"28","author":"WL Heyward","year":"1981","unstructured":"Heyward WL, Lanier AP, Bender TR et al (1981) Primary hepatocellular carcinoma in Alaskan natives, 1969\u20131979. Int J Cancer 28:47\u201350","journal-title":"Int J Cancer"},{"key":"5_CR100","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/gut.2003.034223","volume":"53","author":"HY Hsu","year":"2004","unstructured":"Hsu HY, Chang MH, Ni YH, Chen HL (2004) Survey of hepatitis B surface variant infection in children 15 years after nationwide vaccination program in Taiwan. Gut 53:1499\u2013503","journal-title":"Gut"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/1097-0142(19831115)52:10<1825::AID-CNCR2820521011>3.0.CO;2-M","volume":"52","author":"HC Hsu","year":"1983","unstructured":"Hsu HC, Lin WS, Tsai MJ (1983) Hepatitis B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells. Cancer 52:1825\u20131832","journal-title":"Cancer"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jmv.1890180402","volume":"18","author":"HY Hsu","year":"1986","unstructured":"Hsu HY, Chang MH, Chen DS et al (1986) Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 18:301\u2013307","journal-title":"J Med Virol"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/hep.1840150505","volume":"15","author":"HY Hsu","year":"1992","unstructured":"Hsu HY, Chang MH, Hsieh KH et al (1992) Cellular immune response to hepatitis B core antigen in maternal-infant transmission of hepatitis B virus. Hepatology 15:770\u2013776","journal-title":"Hepatology"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hep.510300511","volume":"30","author":"HY Hsu","year":"1999","unstructured":"Hsu HY, Chang MH, Liaw SH et al (1999) Changes of hepatitis B surface variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30:1312\u20131317","journal-title":"Hepatology"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1086\/651378","volume":"201","author":"HY Hsu","year":"2010","unstructured":"Hsu HY, Chang MH, Ni YH et al (2010) Twenty-year trends in the emergence of hepatitis B surface antigen variants in children and adolescents after universal vaccination in Taiwan. J Infect Dis 201:1192\u20131200","journal-title":"J Infect Dis"},{"key":"5_CR38","first-page":"257","volume":"6","author":"LP Jacobson","year":"1997","unstructured":"Jacobson LP, Zhang BC, Shu YR et al (1997) Oltipratz chemoprevention trial in Qidong, People\u2019s Republic of China: study design and clinical outcomes. Cancer Epidemiol Biomarkers Prev 6:257\u2013265","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5_CR39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3904\/kjim.2001.16.3.153","volume":"16","author":"MK Jang","year":"2001","unstructured":"Jang MK, Lee JY, Lee JH et al (2001) Seroepidemiology of HBV infection in South Korea, 1995 through 1999. Korean J Intern Med 16:153\u2013159","journal-title":"Korean J Intern Med"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/jnci\/djh334","volume":"96","author":"SH Jee","year":"2004","unstructured":"Jee SH, Ohrr H, Sull JW et al (2004) Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 96:1851\u20131855","journal-title":"J Natl Cancer Inst"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0140-6736(05)65598-5","volume":"348","author":"MA Kane","year":"1996","unstructured":"Kane MA (1996) Global status of hepatitis B immunization. Lancet 348:696","journal-title":"Lancet"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00001432-200210000-00002","volume":"15","author":"MA Kane","year":"2002","unstructured":"Kane MA, Brooks A (2002) New immunization initiatives and progress toward the global control of hepatitis B. Curr Opin Infect Dis 15:465\u2013469","journal-title":"Curr Opin Infect Dis"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D Lavanchy","year":"2004","unstructured":"Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis 11:97\u2013107","journal-title":"J Viral Hepatitis"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.bpg.2008.11.002","volume":"22","author":"D Lavanchy","year":"2008","unstructured":"Lavanchy D (2008) Chronic viral hepatitis as a public health issue in the world. Best Pract Res Clin Gastroenterol 22:991\u20131008","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"5_CR45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/hep.1840060306","volume":"6","author":"SD Lee","year":"1986","unstructured":"Lee SD, Lo KJ, Wu JC et al (1986) Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology 6(3):369\u201373","journal-title":"Hepatology"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC et al (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351:1521\u20131531","journal-title":"N Engl J Med"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1478-3231.2010.02388.x","volume":"1","author":"YF Liaw","year":"2011","unstructured":"Liaw YF (2011) Impact of hepatitis B therapy on the long-term outcome of liver disease. Liver Int Suppl 1:117\u2013121","journal-title":"Liver Int Suppl"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0264-410X(91)90135-S","volume":"9","author":"HH Lin","year":"1991","unstructured":"Lin HH, Chang MH, Chen DS et al (1991) Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine 9:457\u2013460","journal-title":"Vaccine"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0022-3476(87)80210-X","volume":"111","author":"HH Lin","year":"1987","unstructured":"Lin HH, Lee TY, Chen DS et al (1987) Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis intrauterine infection with hepatitis B virus. J Pediatr 111:877\u2013881","journal-title":"J Pediatr"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jhep.2006.08.021","volume":"46","author":"SM Lin","year":"2007","unstructured":"Lin SM, Yu ML, Lee CM et al (2007) Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma. J Hepatol 46:45\u201352","journal-title":"J Hepatol"},{"issue":"5\u201311","key":"5_CR51","first-page":"1","volume":"195","author":"SE Livingston","year":"2007","unstructured":"Livingston SE, Simonetti J, McMahon B et al (2007) Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 195(5\u201311):1","journal-title":"J Infect Dis"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/hep.24442","volume":"54","author":"BJ McMahon","year":"2011","unstructured":"McMahon BJ, Bulkow LR, Singleton RJ et al (2011) Elimination of hepatocellular carcinoma and acute hepatitis B in children 25\u00a0years after a hepatitis B newborn and catch-up immunization program. Hepatology 54:801\u2013807","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"5_CR53","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1476-069X-10-S1-S6","volume":"10","author":"R Montesano","year":"2011","unstructured":"Montesano R (2011) Preventing primary liver cancer: the HBV vaccination project in the Gambia (West Africa). Environ Health 10(Suppl 1):S6","journal-title":"Environ Health"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1002\/1097-0142(19911015)68:8<1737::AID-CNCR2820680815>3.0.CO;2-G","volume":"68","author":"YH Ni","year":"1991","unstructured":"Ni YH, Chang MH, Hsu HY et al (1991) Hepatocellular carcinoma in childhood. Clinical manifestations and prognosis. Cancer 68:1737\u20131741","journal-title":"Cancer"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7326\/0003-4819-135-9-200111060-00009","volume":"135","author":"YH Ni","year":"2001","unstructured":"Ni YH, Chang MH, Huang LM et al (2001) Hepatitis B virus infection in children and adolescents in an hyperendemic area: 15\u00a0years after universal hepatitis B vaccination. Ann Intern Med 135:796\u2013800","journal-title":"Ann Intern Med"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1053\/j.gastro.2007.02.055","volume":"132","author":"YH Ni","year":"2007","unstructured":"Ni YH, Huang LM, Chang MH et al (2007) Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 132:1287\u20131293","journal-title":"Gastroenterology"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ijc.1440","volume":"94","author":"DM Parkin","year":"2001","unstructured":"Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153\u2013156","journal-title":"Int J Cancer"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1001\/jama.1989.03420220092033","volume":"261","author":"Y Poovorawan","year":"1989","unstructured":"Poovorawan Y, Sanpavat S, Pongpunlert W et al (1989) Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA 261:3278\u20133281","journal-title":"JAMA"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(98)09148-X","volume":"353","author":"DF Schafer","year":"1999","unstructured":"Schafer DF, Sorrell MF (1999) Hepatocellular carcinoma. Lancet 353:1253\u20131257","journal-title":"Lancet"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/epirev\/mxj009","volume":"28","author":"CW Shepard","year":"2006","unstructured":"Shepard CW, Simard EP, Finelli L et al (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28:112\u2013125","journal-title":"Epidemiol Rev"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJM197504102921503","volume":"292","author":"CE Stevens","year":"1975","unstructured":"Stevens CE, Beasley RP, Tsui J et al (1975) Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292:771\u2013774","journal-title":"N Engl J Med"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0022-3476(98)70272-0","volume":"133","author":"JR Tang","year":"1998","unstructured":"Tang JR, Hsu HY, Lin HH et al (1998) Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr 133:374\u2013377","journal-title":"J Pediatr"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","volume":"142","author":"TC Tseng","year":"2012","unstructured":"Tseng TC, Liu CJ, Yang HC et al (2012) High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology 142:1140\u20131149","journal-title":"Gastroenterology"},{"issue":"23","key":"5_CR64","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1038\/sj.onc.1207773","volume":"29","author":"DJ Tsuei","year":"2004","unstructured":"Tsuei DJ, Hsu HC, Lee PH et al (2004) RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts. Oncogene 29(23):5815\u20135822","journal-title":"Oncogene"},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/hep.24794","volume":"55","author":"F Turati","year":"2012","unstructured":"Turati F, Edefonti V, Talamini R et al (2012) Family history of liver cancer and hepatocellular carcinoma. Hepatology 55:1416\u20131425","journal-title":"Hepatology"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.bpg.2008.11.008","volume":"22","author":"K Herck Van","year":"2008","unstructured":"Van Herck K, Vorsters A, Van Damme P (2008) Prevention of viral hepatitis (B and C) reassessed. Best Pract Res Clin Gastroenterol 22:1009\u20131029","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1046\/j.1365-2893.2003.00440.x","volume":"10","author":"M Zonneveld van","year":"2003","unstructured":"van Zonneveld M, van Nunen AB, Niesters HG et al (2003) Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 10:294\u2013297","journal-title":"J Viral Hepat"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-2006-960171","volume":"27","author":"A Villanueva","year":"2007","unstructured":"Villanueva A, Newell P, Chiang DY et al (2007) Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27:55\u201376","journal-title":"Semin Liver Dis"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1349-7006.2006.00235.x","volume":"97","author":"HC Wang","year":"2006","unstructured":"Wang HC, Huang W, Lai MD et al (2006) Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97:683\u2013688","journal-title":"Cancer Sci"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bmj.325.7364.569","volume":"325","author":"H Whittle","year":"2002","unstructured":"Whittle H, Jaffar S, Wansbrough M et al (2002) Observational study of vaccine efficacy 14\u00a0years after trial of hepatitis B vaccination in Gambian children. BMJ 325:569\u2013573","journal-title":"BMJ"},{"key":"5_CR71","first-page":"507","volume":"9","author":"K Wichajarn","year":"2008","unstructured":"Wichajarn K, Kosalaraksa P, Wiangnon S (2008) Incidence of hepatocellular carcinoma in children in Khon Kaen before and after national hepatitis B vaccine program. Asian Pac J Cancer Prev 9:507\u2013509","journal-title":"Asian Pac J Cancer Prev"},{"key":"5_CR72","unstructured":"World Health Organization (2012) Data, statistics and graphics. Global routine vaccination coverage, (\n                  http:\/\/www.who.int\/immunization_monitoring\/data\/en\/\n                  \n                , accessed Mar 2012)"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2893.2008.01056.x","volume":"16","author":"WM Xu","year":"2009","unstructured":"Xu WM, Cui YT, Wang L et al (2009) Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 16:94\u2013103","journal-title":"J Viral Hepat"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1056\/NEJMoa013215","volume":"347","author":"HI Yang","year":"2002","unstructured":"Yang HI, Lu SN, Liaw YF et al (2002) Hepatitis B e antigen and the risks of hepatocellular carcinoma. N Engl J Med 347:168\u2013174","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"5_CR75","first-page":"172","volume":"78","author":"SH Yeh","year":"2012","unstructured":"Yeh SH, Chen PJ (2012) Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 78(suppl 1):172\u2013179","journal-title":"Oncology"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/oxfordjournals.aje.a009060","volume":"145","author":"MW Yu","year":"1997","unstructured":"Yu MW, Hsu FC, Sheen IS et al (1997) Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 145:1039\u20131047","journal-title":"Am J Epidemiol"}],"container-title":["Recent Results in Cancer Research","Viruses and Human Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-38965-8_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T22:21:56Z","timestamp":1558045316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-38965-8_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,6]]},"ISBN":["9783642389641","9783642389658"],"references-count":75,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-38965-8_5","relation":{},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,6]]}}}